Please login to the form below

Not currently logged in
Email:
Password:

Innovate UK appoints director for health and life sciences

Ian Campbell takes up the newly-created post

Innovate UK Ian CampbellInnovate UK has appointed its first director for health and life sciences, with Ian Campbell taking up the role in Autumn 2016.

In his new position, Campbell will drive the development and delivery of the UK government-sponsored agency's life sciences and health sector.

Campbell currently serves as chief executive officer of Arquer Diagnostics, a UK based diagnostics company specialising in non-invasive tests for the detection of cancer.

Previously, he was commercial director for Bespak Europe, a medical devices manufacturer, and has served as the chief executive officer of Imperial College spin-out company Molecular Vision, which was acquired by Abingdon Health in 2012.

Dr Ruth McKernan, chief executive of Innovate UK, said: “Ian Campbell will make a strong addition to the team at Innovate UK.

“He has extensive entrepreneurial and business experience which make him well-suited to lead our health and life sciences team as we set out our strategy for supporting innovation and growth over the next five years.”

1st August 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics